Payden Equity Income Fund Adviser Cl (PYVAX) NASDAQ
18.48
+0.17(+0.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
18.48
+0.17(+0.93%)
Currency In USD
| Market Cap | N/A |
| Enterprise Value | N/A |
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 142.68 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 142.68 |
| Enterprise/EBITDA | 11.99 |
| Fiscal Year | September 30, 2023 |
| Most Recent Quarter | September 30, 2023 |
| Profit Margin | 12.14 |
| Operating Margin | 0.24 |
| Return On Assets | 0.17 |
| Return On Equity | 0.18 |
| Revenue | 9.2M |
| Revenue/Share | 0 |
| Gross Profit | 9.2M |
| EBITDA | 109.44M |
| Net Income | 111.63M |
| Diluted EPS | 2.77 |
| Total Cash | 0 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.73 |
| Book Value Per Share | 0 |
| 52-Week Change | 13.93 |
| 52-Week High | 18.48 |
| 52-Week Low | 16.18 |
| Moving Average 50 Days | 17.8 |
| Moving Average 200 Days | 17.49 |
| Average Volume | 0 |
| Shares Outstanding | 71.01M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1.06 |
| Trailing Annual Dividend Yield | 5.74 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |